CORLINE

Corline Heparin Technology - Enabling Regenerative Medicine

Coordinatore	NORDICBLUE AB    more  Organization address address: Kristinedalsvaegen 48 city: NACKA postcode: 131 46 contact info Titolo: Mr. Nome: Mats Cognome: Wallnér Email: send email Telefono: 4687184200 Fax: 4687184200
Nazionalità Coordinatore	Sweden [SE]
Totale costo	1˙465˙000 €
EC contributo	1˙135˙500 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2010-1
Funding Scheme	BSG-SME
Anno di inizio	2011
Periodo (anno-mese-giorno)	2011-04-01   -   2013-09-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	NORDICBLUE AB  Organization address address: Kristinedalsvaegen 48 city: NACKA postcode: 131 46 contact info Titolo: Mr. Nome: Mats Cognome: Wallnér Email: send email Telefono: 4687184200 Fax: 4687184200	SE (NACKA)	coordinator	84˙000.00
2	CORLINE SYSTEMS AB  Organization address address: LEFFLERSGATAN 5 city: UPPSALA postcode: 75109 contact info Titolo: Dr. Nome: Henrik Cognome: Nittmar Email: send email Telefono: +46 18 71 30 90 Fax: +46 18 71 30 91	SE (UPPSALA)	participant	538˙500.00
3	BETA-CELL  Organization address address: RESEARCHPARK Z.1. 310 city: ZELLIK postcode: 1731 contact info Titolo: Mr. Nome: Sven Cognome: Andréasson Email: send email Telefono: 3224774349	BE (ZELLIK)	participant	250˙500.00
4	Tissue Regenix Limited  Organization address address: INNOVATION WAY THE BIOCENTRE city: York postcode: Y0105 NY contact info Titolo: Dr. Nome: Antony Cognome: Odell Email: send email Telefono: +44 1904 56 76 09 Fax: +44 1904 38 05 17	UK (York)	participant	231˙000.00
5	Cytonet GmbH & Co. KG  Organization address address: Albert-Ludwig-Grimm-Str. 20 city: Weinheim postcode: 69469 contact info Titolo: Dr. Nome: Lubomir Cognome: Arseniev Email: send email Telefono: +49 511 554 743 22 Fax: +49 511 554 743 64	DE (Weinheim)	participant	13˙500.00
6	Aurigon Life Science GmbH  Organization address address: Bahnhofstrasse 9 - 15 city: Tutzing postcode: D-82327 contact info Titolo: Dr. Nome: Gerhard Cognome: Hager Email: send email Telefono: +49 8 158 2597 30 Fax: +49 8 158259731	DE (Tutzing)	participant	3˙000.00
7	MEDIZINISCHE HOCHSCHULE HANNOVER  Organization address address: Carl-Neuberg-Strasse 1 city: HANNOVER postcode: 30625 contact info Titolo: Mr. Nome: Frank Cognome: Dittrich Email: send email Telefono: 495115000000 Fax: 495115000000	DE (HANNOVER)	participant	3˙000.00
8	Stricent AB  Organization address address: St Lars vag 42 city: Lund postcode: SE22270 contact info Titolo: Mr. Nome: Jerker Cognome: Ringström Email: send email Telefono: +46 46 38 90 00 Fax: +46 46 15 06 99	SE (Lund)	participant	3˙000.00
9	UNIVERSITY OF LEEDS  Organization address address: WOODHOUSE LANE city: LEEDS postcode: LS2 9JT contact info Titolo: Prof. Nome: Eileen Cognome: Ingham Email: send email Telefono: +44 113 343 5691 Fax: +44 113 343 5638	UK (LEEDS)	participant	3˙000.00
10	UPPSALA LANS LANDSTING  Organization address address: SLOTTSGRAND 2A city: UPPSALA postcode: 751 25 contact info Titolo: Prof. Nome: Gunnar Cognome: Tufveson Email: send email Telefono: +46 18 6113116 Fax: +46 18 50 81 27	SE (UPPSALA)	participant	3˙000.00
11	VRIJE UNIVERSITEIT BRUSSEL  Organization address address: PLEINLAAN 2 city: BRUSSEL postcode: 1050 contact info Titolo: Dr. Nome: Christel Cognome: Hendriekcx Email: send email Telefono: +32 2 4774559 Fax: +32 2 4774545	BE (BRUSSEL)	participant	3˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Regenerative Medicine (use of cells and tissue to replace or heal impaired functions in the body, RM) is one of the fastest growing areas in today’s medicine, and has the potential to offer treatment to patients with diseases that are currently untreatable. In many new areas of RM there is however a need to improve the outcome of RM concepts and technologies for it to become a viable option to traditional medicine, or even to motivate the risk of clinical trials and treatments. One of the main problems in several RM areas is that a large portion of the cell and tissue material is lost or made dysfunctional during and shortly after transplantation and that the transplant does not connect to the host tissue as a functional new graft. The specific scientific objective of this project is twofold: 1) to clinically test and prove that Corline Heparin Surfaces (CHS) can be used to protect donated human insulin producing cells that are transplanted to severe cases of Diabetes Type 1 patients, and 2) to broaden the application of the technology and show that the CHS technology can function as a protective and revascularization promoting technology for other Regenerative Medicine areas. The goal is to show CHS’s further applicability to Liver Cell therapy, Xeno transplantation of Islet of Langerhans and to Tissue Engineering In addition to the detailed scientific objective, this project has a specific technological objective. The technological objective of this project is to, in partnerships with the participating SMEs, improve European top grade clinical Regenerative Medicine products by combining them with the CHS technology, transferring the application knowledge and integrating the CHS technology into the partners’ cell and tissue production processes, and to set up a reliable sourcing chain with supply and production of reagents and tissue products to end-user.'

Introduzione (Teaser)

EU research has funded a remarkable breakthrough in regenerative medicine. Protection and encapsulation for cells in a tissue graft are poised to enter clinical practise.